Mbiomics raises €13.0M Series A round
23 March 2023· Munich, Germany· health, biotech, ai, b2b, software_hardware
The funding is intended to build the company's microbiome profiling platform, accelerate the identification of lead drug candidates, expand R&D teams and facilities in Munich, and increase activities in the United States.
Investors
LeadMIG Capital
Also participating
High-Tech GründerfondsBayern KapitalGerman AcceleratorPrivate Seed Investors
About Mbiomics
Stage
Series A
Headquarters
Munich, Germany
Founded
2020
Team Size
21–50
Sectors
healthbiotechaib2bsoftware_hardware